Aethlon Medical Inc. AEMD
Medical/Dental Instruments · data as of November 13, 2026
Aethlon Medical Inc. (AEMD) is a healthcare company listed in the US with a market value of about $9M.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -111%.
About Aethlon Medical
Aethlon Medical is listed in the US and classified in medical/dental instruments. Revenue went from $762417 in 2015 to $574245 in 2023, a decline of about 3.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 2525% over three years (dilution for shareholders).
Score: 0.4 / 5
Checks passed
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $574245 | $294165 | $659104 | $650187 | $229625 | $149625 | $392073 |
| Net income | -$7M | -$13M | -$12M | -$12M | -$10M | -$8M | -$6M | -$6M | -$6M | -$7M |
| Free cash flow | -$7M | -$8M | -$10M | -$11M | -$10M | -$7M | -$5M | -$4M | -$4M | -$4M |
| EPS (diluted) | $-10.61 | $-85.77 | $-388.70 | $-468.80 | $-568.00 | $-520.00 | $-1495.99 | $-4103.97 | $-1199.99 | $-11279.91 |
| Net margin | — | — | — | -2094.9% | -3540.9% | -1196.6% | -980.3% | -2697.8% | -3795.9% | -1855.8% |
| ROIC | -139.6% | -161.8% | -148.8% | -57.8% | -46.5% | -65.5% | -49.0% | -131.1% | -54.7% | -403.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $13.25, 150% above the current price; targets range from $1.50 to $25.00; the consensus rating is “none”; expected EPS is $-5.74 for the fiscal year ending March 31, 2027.
Frequently asked questions
Does Aethlon Medical pay a dividend?
Not currently.
Is Aethlon Medical a good stock to buy?
We do not give buy or sell advice. Aethlon Medical scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.